Contact
searchSearch
HMP Global

Opioid Use Disorder Topic Center

Featured Article

News
Methadone Access Reform Needed to Address the US Opioid Crisis
03/08/2024

Emry Lloyd

Emry Lloyd
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis...
03/08/2024
Pharmacy Learning Network
Quiz
Calculating the Global Scope of OUD
12/05/2023
How many people experience opioid use disorder (OUD) globally?
How many people experience opioid use disorder (OUD) globally?
How many people experience...
12/05/2023
Pharmacy Learning Network
News
Navigating the Opioid Epidemic: Research Insights, the DSM-5, and the Mainstreaming Addiction Treatment Act
12/04/2023
Danielle Sposato
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on...
12/04/2023
Pharmacy Learning Network
Quiz
True or False: Unlawful Opioid Distribution Statistics
12/01/2023
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health...
12/01/2023
Pharmacy Learning Network
News
Crucial Research Funding: Unveiling Strategies to Combat Widespread and Deadly Addictions in the US
11/22/2023
Danielle Sposato
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys...
11/22/2023
Pharmacy Learning Network
Quiz
Long-Term Pain Management With Opioids
11/22/2023
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are...
11/22/2023
Pharmacy Learning Network
News
Understanding the Opioid Epidemic: Diagnosis, Risk Factors, Treatment Options, and Addiction Reduction Strategies
11/22/2023
Hannah Musick
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the...
11/22/2023
Pharmacy Learning Network
News
Chemical Engineers Receive $3.5 Million Grant to Investigate Adolescent Exposure and Opioid Addiction
11/20/2023
Hannah Musick
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of...
11/20/2023
Pharmacy Learning Network
News
Narcan, Now Available Without a Prescription, Can Still Be Hard to Get
10/11/2023
Jackie Fortiér; Nicole Leonard
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and...
10/11/2023
Pharmacy Learning Network
News
Decreases in Opioid Prescribing by State Varied After CDC Guidance
10/06/2023
Jolynn Tumolo
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends...
10/06/2023
Pharmacy Learning Network
News
More Schools Stock Overdose Reversal Meds, but Others Worry About Stigma
10/03/2023
Virginia Garcia Pivik; Rae Ellen Bichell
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states...
10/03/2023
Pharmacy Learning Network

Newsfeed

News
Methadone Access Reform Needed to Address the US Opioid Crisis
03/08/2024

Emry Lloyd

Emry Lloyd
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis intensifies, US federal regulations must undergo necessary revisions, ensuring access to life-saving medications and aligning with standards set by other advanced nations.
As the overdose crisis...
03/08/2024
Pharmacy Learning Network
News
Navigating the Opioid Epidemic: Research Insights, the DSM-5, and the Mainstreaming Addiction Treatment Act
12/04/2023
Danielle Sposato
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on the rise across the world and has transformed into an epidemic in the US, it needs a better understanding from health care professionals and government intervention along with resources and a team-based...
"While opioid use disorder is on...
12/04/2023
Pharmacy Learning Network
News
Crucial Research Funding: Unveiling Strategies to Combat Widespread and Deadly Addictions in the US
11/22/2023
Danielle Sposato
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys researchers have secured federal grants totaling almost $25 million to propel their investigations and clinical trials aimed at understanding and treating addiction.
Sanford Burnham Prebys...
11/22/2023
Pharmacy Learning Network
News
Understanding the Opioid Epidemic: Diagnosis, Risk Factors, Treatment Options, and Addiction Reduction Strategies
11/22/2023
Hannah Musick
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the diagnosis and risk factors of opioid use disorder, as well as the ineffectiveness of opioids as long-term pain medications, the physical manifestations and effects of opioid abuse, the need for substance use...
This summary addresses the...
11/22/2023
Pharmacy Learning Network
News
Chemical Engineers Receive $3.5 Million Grant to Investigate Adolescent Exposure and Opioid Addiction
11/20/2023
Hannah Musick
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of Health’s National Institute on Drug Abuse is awarding a 5-year, $3.5 million grant to the Virginia Tech Department of Chemical Engineering’s pioneering research to understand how adolescent exposure may contribute...
The National Institutes of...
11/20/2023
Pharmacy Learning Network
News
Narcan, Now Available Without a Prescription, Can Still Be Hard to Get
10/11/2023
Jackie Fortiér; Nicole Leonard
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and pharmacies nationwide began stocking and selling the country’s first over-the-counter version of naloxone, a medication that can stop a potentially fatal overdose from opioids, but it’s unclear whether the move will...
Last month, drugstores and...
10/11/2023
Pharmacy Learning Network
News
Decreases in Opioid Prescribing by State Varied After CDC Guidance
10/06/2023
Jolynn Tumolo
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends and variations in opioid prescribing may help inform future efforts to improve prescribing and reduce related harm, researchers advised.
Understanding state-level trends...
10/06/2023
Pharmacy Learning Network
News
More Schools Stock Overdose Reversal Meds, but Others Worry About Stigma
10/03/2023
Virginia Garcia Pivik; Rae Ellen Bichell
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states that ensure schools have access to the opioid overdose reversal medication naloxone for free or at reduced cost. But most districts hadn’t signed up by the start of the school year for a state distribution...
Colorado is among several states...
10/03/2023
Pharmacy Learning Network
News
Artificial Intelligence May Influence Whether Patients Can Get Pain Medication
09/06/2023
Andy Miller; Sam Whitehead
To contain the opioid crisis, health and law enforcement agencies have turned to technology to monitor doctor and patient prescription data, but experts have raised questions about how these systems work and worry about their accuracy and...
To contain the opioid crisis, health and law enforcement agencies have turned to technology to monitor doctor and patient prescription data, but experts have raised questions about how these systems work and worry about their accuracy and...
To contain the opioid crisis,...
09/06/2023
Pharmacy Learning Network
News
OUD Treatment Inequities Identified for Medicaid Beneficiaries With Disabilities
03/16/2023
Maria Asimopoulos
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use disorder treatment trends among Medicaid members with vs without physical, sensory, developmental, and cognitive disabilities.
Researchers compared opioid use...
03/16/2023
First Report Managed Care
PharmLaw
Iowa Attorney General Accuses Insulin Makers and PBMs of Deceptive Pricing Practices
02/03/2026
Juliet Gallagher
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna Bird has filed a sweeping lawsuit against major insulin manufacturers and pharmacy benefit managers (PBMs), alleging a coordinated, years-long scheme to artificially inflate the prices of insulin and other...
Iowa Attorney General Brenna...
02/03/2026
Pharmacy Learning Network
News
Antacid Tablets Recalled Due to Failed Disintegration Specifications
01/29/2026
Hannah Musick
The US Food and Drug Administration (FDA) has issued a Class II recall for INON ACE Antacid Tablets due to failed disintegration specifications, which may reduce the product’s effectiveness in relieving indigestion and gas.
The US Food and Drug Administration (FDA) has issued a Class II recall for INON ACE Antacid Tablets due to failed disintegration specifications, which may reduce the product’s effectiveness in relieving indigestion and gas.
The US Food and Drug...
01/29/2026
Pharmacy Learning Network
News
Glycopyrrolate Oral Solution Recalled Due to Degradation Specification Failure
01/29/2026
Hannah Musick
A Class III recall has been issued for glycopyrrolate oral solution due to degradation/impurity specification failure.
A Class III recall has been issued for glycopyrrolate oral solution due to degradation/impurity specification failure.
A Class III recall has been...
01/29/2026
Pharmacy Learning Network
News
Icosapent Ethyl Capsules Under Class II Recall
01/29/2026
Hannah Musick
The US Food and Drug Administration (FDA) is monitoring a Class II recall of icosapent ethyl capsules after capsule leakage caused subpotency, potentially affecting cardiovascular risk reduction therapy in patients with elevated triglycerides.
The US Food and Drug Administration (FDA) is monitoring a Class II recall of icosapent ethyl capsules after capsule leakage caused subpotency, potentially affecting cardiovascular risk reduction therapy in patients with elevated triglycerides.
The US Food and Drug...
01/29/2026
Pharmacy Learning Network
PharmLaw
PCMA Sues California Over SB 41, Challenging PBM Fiduciary Duties Under ERISA
01/27/2026
Juliet Gallagher
California’s most ambitious pharmacy benefit manager (PBM) reform effort has drawn an immediate legal challenge, as the Pharmaceutical Care Management Association (PCMA) filed a federal lawsuit contesting key provisions of Senate Bill 41 (SB...
California’s most ambitious pharmacy benefit manager (PBM) reform effort has drawn an immediate legal challenge, as the Pharmaceutical Care Management Association (PCMA) filed a federal lawsuit contesting key provisions of Senate Bill 41 (SB...
California’s most ambitious...
01/27/2026
Pharmacy Learning Network
News
Recall Issued for Diclofenac Sodium Topical Gel Due to pH Specification Failure
01/22/2026
Grace Taylor, MS, MA
The US Food and Drug Administration (FDA) is overseeing a nationwide, voluntary Class III recall of diclofenac sodium topical gel 1% after the product failed to meet pH specifications, affecting more than 92 000 tubes distributed across the...
The US Food and Drug Administration (FDA) is overseeing a nationwide, voluntary Class III recall of diclofenac sodium topical gel 1% after the product failed to meet pH specifications, affecting more than 92 000 tubes distributed across the...
The US Food and Drug...
01/22/2026
Pharmacy Learning Network
News
Furosemide 40 mg Tablets Recalled Due to Foreign Substance Contamination
01/22/2026
Grace Taylor, MS, MA
The US Food and Drug Administration (FDA) is alerting pharmacists to a voluntary Class II nationwide recall of Furosemide 40 mg tablets after a foreign substance was detected in a distributed lot.
The US Food and Drug Administration (FDA) is alerting pharmacists to a voluntary Class II nationwide recall of Furosemide 40 mg tablets after a foreign substance was detected in a distributed lot.
The US Food and Drug...
01/22/2026
Pharmacy Learning Network
PharmLaw
Compounding Pharmacy Sues Eli Lilly, Novo Nordisk Over Alleged GLP-1 Antitrust Violations
01/21/2026
Juliet Gallagher
An Arizona-based compounding pharmacy has filed an antitrust lawsuit accusing Eli Lilly and Novo Nordisk of unlawfully restricting competition in the market for GLP-1 medications, escalating a legal battle over compounded versions of...
An Arizona-based compounding pharmacy has filed an antitrust lawsuit accusing Eli Lilly and Novo Nordisk of unlawfully restricting competition in the market for GLP-1 medications, escalating a legal battle over compounded versions of...
An Arizona-based compounding...
01/21/2026
Pharmacy Learning Network
News
Imprimis NJOF Initiates Class II Recall of Tri-Moxi+ Intraocular Injection Due to Particulate Matter
01/15/2026
Juliet Gallagher
Imprimis NJOF, LLC is recalling Tri-Moxi+® (Triamcinolone 9 mg/0.6 mL, Moxifloxacin 0.6 mg/0.6 mL) Single-Use Intraocular Injection, NDC 71384-746-06. The recall encompasses 314 boxes totaling 6280 pre-filled syringes. Affected product...
Imprimis NJOF, LLC is recalling Tri-Moxi+® (Triamcinolone 9 mg/0.6 mL, Moxifloxacin 0.6 mg/0.6 mL) Single-Use Intraocular Injection, NDC 71384-746-06. The recall encompasses 314 boxes totaling 6280 pre-filled syringes. Affected product...
Imprimis NJOF, LLC is recalling...
01/15/2026
Pharmacy Learning Network
News
FDA Reports Class II Recall of Imprimis Intraocular Dexamethasone Injections Due to Glass Particulates
01/15/2026
Juliet Gallagher
Imprimis NJOF, LLC is recalling two compounded intraocular injectable drug products distributed nationwide in the US. The first product, Dexamethasone Moxifloxacin Intraocular Injection (1 mg/mL and 5 mg/mL, 1 mL, Rx only; NDC 71384-512-0.1),...
Imprimis NJOF, LLC is recalling two compounded intraocular injectable drug products distributed nationwide in the US. The first product, Dexamethasone Moxifloxacin Intraocular Injection (1 mg/mL and 5 mg/mL, 1 mL, Rx only; NDC 71384-512-0.1),...
Imprimis NJOF, LLC is recalling...
01/15/2026
Pharmacy Learning Network

Interactive Features

Quiz
Calculating the Global Scope of OUD
12/05/2023
How many people experience opioid use disorder (OUD) globally?
How many people experience opioid use disorder (OUD) globally?
How many people experience...
12/05/2023
Pharmacy Learning Network
Quiz
True or False: Unlawful Opioid Distribution Statistics
12/01/2023
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health Care Fraud Strike Force, operating since March 2007, has charged more than 5000 defendants who collectively billed federal health care programs and private insurance companies close to $28 billion.
True or False: The DOJ’s Health...
12/01/2023
Pharmacy Learning Network
Quiz
Long-Term Pain Management With Opioids
11/22/2023
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are effective long-term pain medications.
True or False: Opioids are...
11/22/2023
Pharmacy Learning Network
Videos
Correlation Between Opioid Overdoses With Alcohol, Benzodiazepine Use
05/13/2020
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of Medicine, Boston University School of Medicine, discusses why alcohol and benzodiazepine co-involvement was common among opioid overdose-related deaths.
Marco Tori, MD, Department of...
05/13/2020
Pharmacy Learning Network
Quiz
How New Alabama Law Will Affect Independent Pharmacies
10/22/2025
True or False: Under Alabama’s Community Pharmacy Relief Act (S.B. 252), pharmacy benefit managers (PBMs) must reimburse independent pharmacies at the same rate as Medicaid, which is generally a $10.64 dispensing fee per prescription.
True or False: Under Alabama’s Community Pharmacy Relief Act (S.B. 252), pharmacy benefit managers (PBMs) must reimburse independent pharmacies at the same rate as Medicaid, which is generally a $10.64 dispensing fee per prescription.
True or False: Under Alabama’s...
10/22/2025
Pharmacy Learning Network
Quiz
Lawsuit Against Walgreens Over Religious Accommodations
10/08/2025
True or False: The pharmacists in the lawsuit against Walgreens claim they were denied religious accommodations for both abortion and gender-affirming medications under Minnesota law.
True or False: The pharmacists in the lawsuit against Walgreens claim they were denied religious accommodations for both abortion and gender-affirming medications under Minnesota law.
True or False: The pharmacists...
10/08/2025
Pharmacy Learning Network
Quiz
Pharmacist Sentenced for Animal Cruelty
09/15/2025
Learn more about a pharmacist who was sentenced to prison for using controlled dangerous substances to kill his dog.  
Learn more about a pharmacist who was sentenced to prison for using controlled dangerous substances to kill his dog.  
Learn more about a pharmacist...
09/15/2025
Pharmacy Learning Network
Quiz
New York Executive Order Expands COVID Vaccine Access
09/10/2025
Learn more about a New York executive order that is breaking with FDA restrictions on COVID vaccines to expand access.
Learn more about a New York executive order that is breaking with FDA restrictions on COVID vaccines to expand access.
Learn more about a New York...
09/10/2025
Pharmacy Learning Network
Quiz
Pharmacy Compliance and Controlled Substance Oversight
08/28/2025
Learn more about how pharmacies can maintain compliance with the Controlled Substances Act to avoid legal and financial risk.
Learn more about how pharmacies can maintain compliance with the Controlled Substances Act to avoid legal and financial risk.
Learn more about how pharmacies...
08/28/2025
Pharmacy Learning Network
Quiz
Key Factors in Asthma Wrongful Death Suit
08/21/2025
What was the primary legal issue in the wrongful death case brought by Cole Schmidtknecht’s parents against Optum Rx and Walgreens?
What was the primary legal issue in the wrongful death case brought by Cole Schmidtknecht’s parents against Optum Rx and Walgreens?
What was the primary legal issue...
08/21/2025
Pharmacy Learning Network
Quiz
Assessing Health Care Fraud Damages
07/18/2025
True or False: Between 2013 and 2017, Prime Aid Union City submitted false claims and received over $65 million in reimbursements for medications that were never provided, ordered, or stocked.
True or False: Between 2013 and 2017, Prime Aid Union City submitted false claims and received over $65 million in reimbursements for medications that were never provided, ordered, or stocked.
True or False: Between 2013 and...
07/18/2025
Pharmacy Learning Network
Quiz
Cholinesterase Inhibitors in Alzheimer Disease Treatment
06/12/2025
True or False: Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, are disease-modifying therapies that significantly delay the progression of early Alzheimer disease by reducing amyloid-beta accumulation.TrueFalse
True or False: Cholinesterase inhibitors, such as donepezil, rivastigmine, and galantamine, are disease-modifying therapies that significantly delay the progression of early Alzheimer disease by reducing amyloid-beta accumulation.TrueFalse
True or False: Cholinesterase...
06/12/2025
Pharmacy Learning Network
Quiz
Alzheimer Disease Treatment Types
05/05/2025
True or False: Donepezil, rivastigmine, and galantamine are all FDA-approved acetylcholinesterase inhibitors indicated for the treatment of mild to severe Alzheimer disease.
True or False: Donepezil, rivastigmine, and galantamine are all FDA-approved acetylcholinesterase inhibitors indicated for the treatment of mild to severe Alzheimer disease.
True or False: Donepezil,...
05/05/2025
Pharmacy Learning Network
Quiz
Mechanism of Action in Alzheimer Disease Medication
04/22/2025
What is the primary mechanism of action of FDA-approved drug Lecanemab (Leqembi) in treating early Alzheimer’s disease?
What is the primary mechanism of action of FDA-approved drug Lecanemab (Leqembi) in treating early Alzheimer’s disease?
What is the primary mechanism of...
04/22/2025
Pharmacy Learning Network

Subscribe Today

Pharmacy Learning Network Newsletter

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use